Serum zinc levels in cancer patients are low and difficult to elevate when complicated by liver cirrhosis: A retrospective study

In this study, we analyzed blood zinc concentration in patients with various cancer types and the degree of improvement in relation to the underlying disease following treatment with zinc preparations. Serum zinc levels of 530 cancer patients whose blood zinc levels were measured at our hospital from 2016 to 2021 were retrospectively examined in accordance with the primary disease. Changes in zinc levels were analyzed in 155 patients whose zinc levels had been measured on 2 or more occasions in accordance with whether they had received zinc preparations. In addition, the concentration course of zinc before and after zinc formulation administration in 73 patients was examined in accordance with the presence or absence of liver cirrhosis complications. Mean serum zinc levels were below normal in all carcinomas measured, and zinc levels were significantly lower in cirrhosis–hepatocarcinoma cases than in other primary disease cases. Furthermore, serum zinc levels in patients who did not receive zinc preparations decreased significantly over time. In patients who received zinc preparations, the elevated levels of zinc after treatment were significantly lower in patients with cirrhosis than in those without cirrhosis. There was a weak inverse correlation between pre-dose zinc concentration and increased zinc concentration in patients with cirrhosis. In the analysis of covariance, the presence of liver cirrhosis was predominantly correlated with elevated zinc per dose. In summary, serum zinc levels in cancer patients are low and especially low in cancer patients with liver cirrhosis compared with those without cirrhosis after the administration of zinc preparations.

[1]  A. Prescha,et al.  Serum and Whole Blood Cu and Zn Status in Predicting Mortality in Lung Cancer Patients , 2020, Nutrients.

[2]  Y. Cho,et al.  Serum zinc level and hepatic fibrosis in patients with nonalcoholic fatty liver disease , 2020, PloS one.

[3]  D. Skrajnowska,et al.  Role of Zinc in Immune System and Anti-Cancer Defense Mechanisms , 2019, Nutrients.

[4]  Ying Wang,et al.  Association between serum zinc levels and lung cancer: a meta-analysis of observational studies , 2019, World Journal of Surgical Oncology.

[5]  N. Hiramatsu,et al.  Long-Term Zinc Supplementation Improves Liver Function and Decreases the Risk of Developing Hepatocellular Carcinoma , 2018, Nutrients.

[6]  M. Navarro-Alarcón,et al.  Serum zinc and copper concentrations and ratios in cirrhotic patients: correlation with severity index. , 2018, Nutricion hospitalaria.

[7]  A. Tjønneland,et al.  Pre-diagnostic copper and zinc biomarkers and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition cohort , 2017, Carcinogenesis.

[8]  K. Tomiyama,et al.  [Biological functions of tin and disease]. , 2016, Nihon rinsho. Japanese journal of clinical medicine.

[9]  H. Wedemeyer,et al.  The role of zinc in liver cirrhosis. , 2015, Annals of hepatology.

[10]  L. Rink,et al.  Chelation of Free Zn2+ Impairs Chemotaxis, Phagocytosis, Oxidative Burst, Degranulation, and Cytokine Production by Neutrophil Granulocytes , 2016, Biological Trace Element Research.

[11]  H. Te,et al.  Screening for Zinc Deficiency in Patients with Cirrhosis: When Should We Start? , 2015, Digestive Diseases and Sciences.

[12]  K. Higuchi,et al.  Serum zinc value in patients with hepatitis virus-related chronic liver disease: association with the histological degree of liver fibrosis and with the severity of varices in compensated cirrhosis , 2014, Journal of clinical biochemistry and nutrition.

[13]  R. Cousins.  Gastrointestinal factors influencing zinc absorption and homeostasis. , 2010, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.

[14]  H. Mazdak,et al.  The comparative study of serum iron, copper, and zinc levels between bladder cancer patients and a control group , 2010, International Urology and Nephrology.

[15]  Ioannis I. Stamoulis,et al.  Zinc and the Liver: An Active Interaction , 2007, Digestive Diseases and Sciences.

[16]  M. Petrovecki,et al.  Serum concentration of zinc, copper, manganese and magnesium in patients with liver cirrhosis. , 2006, Collegium antropologicum.

[17]  A. Arcasoy,et al.  Zinc plasma levels after oral zinc tolerance test in nonalcoholic cirrhosis , 1988, Digestive Diseases and Sciences.

[18]  N. Krebs,et al.  Overview of zinc absorption and excretion in the human gastrointestinal tract. , 2000, The Journal of nutrition.

[19]  W. Maret,et al.  Zinc and Health: Current Status and Future Directions The Function of Zinc Metallothionein: A Link between Cellular Zinc and Redox State 1,2 , 2000 .

[20]  Yushan Pan,et al.  Comparison of serum Zn, Cu and Se contents between healthy people and patients in high,middle and low incidence areas of gastric cancer of Fujian Province. , 1999, World journal of gastroenterology.

[21]  P. Fraker,et al.  Zinc: health effects and research priorities for the 1990s. , 1994, Environmental health perspectives.

[22]  K. Summer,et al.  Metallothionein in human liver and kidney: relationship to age, sex, diseases and tobacco and alcohol use. , 1988, Journal of trace elements and electrolytes in health and disease.

[23]  M E Wastney,et al.  Kinetic analysis of zinc metabolism and its regulation in normal humans. , 1986, The American journal of physiology.

[24]  D. Häussinger,et al.  The influence of portosystemic shunting on zinc and vitamin A metabolism in liver cirrhosis. , 1983, Hepato-gastroenterology.

[25]  M. Yukawa,et al.  Distribution of trace elements in the human body determined by neutron activation analysis. , 1980, Archives of environmental health.

[26]  G. Johnston,et al.  Zinc metabolism in humans after oral and intravenous administration of Zn-69m. , 1979, The American journal of clinical nutrition.